Showing results (71-80 of 533) with videos related to

Sort By:
Pageof 54
Haematologica|May 13, 2010
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemiasWilliam Blum, Mitch A Phelps, Rebecca B Klisovic, et al.
Melanoma Research|May 27, 2005
Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanomaDino D Klisovic, Marko I Klisovic, David Effron, et al.
Blood Reviews|December 4, 2025
Myelofibrosis-associated extramedullary hematopoiesis: Insights into hepatic, pulmonary, and thrombotic complicationsIdoroenyi Amanam, Salman Otoukesh, Vinod Pullarkat, et al.
Cancer Genomics & Proteomics|April 26, 2024
Genomic Frequencies of Dynamic DNA Sequences and Mammalian LifespanMarianna Martella, Nadia Carlesso, Zoë A E Waller, et al.
Blood|January 17, 2013
Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic targetIl-Kyoo Park, Anjali Mishra, Jason Chandler, et al.
Cell and Tissue Research|September 27, 2003
Characterization of leukemia-associated Rho guanine nucleotide exchange factor (LARG) expression during murine developmentBrian Becknell, Tiansheng Shen, Eman Maghraby, et al.
The AAPS Journal|February 9, 2007
Metabolism of GTI-2040, a phosphorothioate oligonucleotide antisense, using ion-pair reversed phase high performance liquid chromatography (HPLC) coupled with electrospray ion-trap mass spectrometryXiaohui Wei, Guowei Dai, Zhongfa Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantationWilliam Blum, Brian J Bolwell, Gary Phillips, et al.
Biochemistry|February 25, 2025
Disordered C-Terminus Plays a Critical Role in the Activity of the Small GTPase RanWenyuan Wei, Melissa Valerio, Ning Ma, et al.
Leukemia Research|May 30, 2006
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapseJoseph Moore, Karen Seiter, Jonathan Kolitz, et al.
Pageof 54